Clinical Use Cases
FlowSight predicts branch-level flow/pressure so you can triage and plan with fewer surprises in the lab.
Compare All Procedures
Overview of inputs, outputs, and decision points across all supported procedures
| Procedure | Clinical Goal | Inputs | Outputs | Primary Metric | Typical Decision |
|---|---|---|---|---|---|
| Pulmonary Embolism (PE) | Identify who benefits from thrombectomy vs anticoagulation alone | CTA-PE segmentation, HR/BP, clot location/burden (if known) | Predicted branch flows, mean PA pressure change, RV afterload proxy | RV afterload proxy | Proceed to thrombectomy vs anticoagulate and monitor |
| Prostate Artery Embolization (PAE) | Target dominant supply and estimate embolic volume while reducing non-target risk | Pelvic CTA/DSA or CBCT centerlines, BP/HR, planned particle size | Dominant vessel ranking, embolic volume range, non-target risk proxy | Dominant vessel flow | Select target branch + starting embolic volume |
| Geniculate Artery Embolization (GAE) | Reduce pain by occluding key geniculate branches, safeguarding skin perfusion | Geniculate branch map, BP/HR, planned occlusion targets | Collateral redistribution prediction, skin perfusion proxy, suggested resistance change | Skin perfusion proxy | Confirm target branches, adjust embolic volume |
| Liver Y-90 | Dose partitioning per artery to meet tumor control and shunt limits | Hepatic artery tree, injection site, tumor territories, shunt prior | Tumor vs normal flow split, lung shunt proxy, per-artery dose suggestion | Tumor vs normal flow ratio | Choose injection site and per-artery dose |
Detailed Procedure Analysis
Clinical goals, inputs, outputs, and typical decisions for each supported procedure
Pulmonary Embolism (PE)
Clinical Goal
Identify who benefits from thrombectomy vs anticoagulation alone.
- CTA-PE segmentation
- HR/BP
- Clot location/burden (if known)
- Predicted branch flows
- Mean PA pressure change
- RV afterload proxy
Proceed to thrombectomy vs anticoagulate and monitor.
Prostate Artery Embolization (PAE)
Clinical Goal
Target dominant supply and estimate embolic volume while reducing non-target risk.
- Pelvic CTA/DSA or CBCT centerlines
- BP/HR
- Planned particle size
- Dominant vessel ranking
- Embolic volume range
- Non-target risk proxy
Select target branch + starting embolic volume.
Geniculate Artery Embolization (GAE)
Clinical Goal
Reduce pain by occluding key geniculate branches, safeguarding skin perfusion.
- Geniculate branch map
- BP/HR
- Planned occlusion targets
- Collateral redistribution prediction
- Skin perfusion proxy
- Suggested resistance change
Confirm target branches, adjust embolic volume.
Liver Y-90
Clinical Goal
Dose partitioning per artery to meet tumor control and shunt limits.
- Hepatic artery tree, injection site
- Tumor territories
- Shunt prior
- Tumor vs normal flow split
- Lung shunt proxy
- Per-artery dose suggestion
Choose injection site and per-artery dose.